Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2156
Title: Prospects and Problems in Emerging Pharmaceutical Market: Gulf Cooperation Council Countries
Authors: Charanath Sivakumar
Arabinda Bhandari
Issue Date: 2020
Publisher: Management Matters
Abstract: The purpose of this viewpoint article is to critically evaluate Gulf Cooperation Council (GCC) countries as an emerging pharmaceutical market through VUCA frame work and to identify prospects and problems. Within the literature, prospects and problems in GCC countries as an emerging pharmaceutical market are not fully addressed vis a vis VUCA environment and this is the gap the study addresses. This is an explorative qualitative study based on the author’s working experience in GCC region & discussion with stakeholders like regulatory authority, channel partners and Physicians. This study may provide the subtle insights to offset the impact of VUCA business environment prevailing in GCC pharmaceutical market. This study may be used to maneuver the resources to yield competitive advantage to pharmaceutical business in GCC countries and for new entrants.
URI: http://localhost:8080/xmlui/handle/123456789/2156
Appears in Collections:Management Department

Files in This Item:
File SizeFormat 
PU-SOM-21.pdf164.52 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.